Secondary Myelofibrosis market Size, Share & Forecast Report 2024-2031
Market overview
Secondary Myelofibrosis market is estimated to grow at a CAGR of 6% during the forecast period 2024-2031.
The Secondary Myelofibrosis market—covering drug therapies, bone-marrow transplantation options, supportive care and hospital/specialty services is seeing growing clinical and commercial attention as cases of underlying myeloproliferative neoplasms (notably...
0 Comments
0 Shares